Searched for
AUROBINDO PHARMA CHINA
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Market bets on Aurobindo as Europe, US sales show uptickAurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...
- Aurobindo arm to acquire additional 20% stake in JV firmAurobindo Pharma is set to increase its stake in its China joint venture. The company will acquire an additional 20 percent for USD 5.12 mi...
- Aurobindo Pharma expects China plant to break even at EBITDA level this yearAurobindo Pharma anticipates its China facility will achieve break-even by Q3 FY26. Production is ramping up after commencing operations in...
- Aurobindo Pharma to commence supplies to Europe from China plant in AprilAurobindo Pharma will start supplying products from its new China facility to Europe by April 2024. The company is ramping up production af...
- How will Biosecure Act impact Indian pharma companies? Aditya Khemka explainsWe own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on th...
- Aurobindo Pharma to commercialise China plant in third quarter of FY25: CFOAurobindo Pharma's China facility is set to start production in the next quarter, with full-scale output expected in the next fiscal year. ...
- Aurobindo Pharma's price correction is a good entry point: What makes it stock pick of the weekAurobindo has a good generic ecosystem and with its vertically integrated model and low product concentration, it should be able to tide ov...
- Buy Aurobindo Pharma, target price Rs 527: Nirmal BangWith China resuming supplies of raw materials, potential disruption in manufacturing is now no longer a concern.
- Inventory buffer to keep pharma healthy for now“Right now, we are good on supplies, but obviously it cannot continue indefinitely,” Sharma added.
- In beaten down Pharma Inc, Aurobindo still offers hopeIn the last one year, the ET Pharma Index has fallen by 21 per cent.
- Aurobindo Pharma arm enters pact to form JV in China with Luoxin"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharm...
- Aurobindo Pharma Q3 net up 9.81 pc to Rs 188.63 crDrug firm Aurobindo Pharma today said its consolidated net profit rose by 9.81 per cent to Rs 188.63 crore for the third quarter ended Dece...
- Aurobindo: Proceeds from stake sale to beef up cash flowsFrom being a low-margin pharma manufacturer, Aurobindo Pharma is transforming itself into a high-margin formulations player.
- Aurobindo to divest stake in China armGeneric drugmaker Aurobindo Pharma has decided to divest its stake in loss-making Chinese subsidiary , Aurobindo (Datong) Bio Pharma (ADBPL...
- Aurobindo to divest 80% stake in China arm to SinopharmGeneric drug maker Aurobindo Pharma today said it will divest nearly 80 per cent of its stake in its loss making Chinese subsidiary to Chin...
- Aurobindo, AstraZeneca ink supply pactAurobindo Pharma, which has been working to transform itself from a low-margin bulk drugs producer into a high-margin formulations player, ...
- StanChart PE Offloads 2.5% in Aurobindo PharmaStandard Chartered Private Equity has made a partial exit for its investment in Aurobindo Pharma for about Rs 95 crore.
- Aurobindo Pharma to divest Chinese armHyderabad-based Aurobindo Pharma has decided to disinvest its loss-making subsidiary in China while acquiring a small manufacturing unit in...
Load More
